Salmon SE - Search Results

1

Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer.

Salmon SE, Dalton WS, Grogan TM, Plezia P, Lehnert M, Roe DJ, Miller TP. Salmon SE, et al. Blood. 1991 Jul 1;78(1):44-50. Blood. 1991. PMID: 1676918 Free article. Clinical Trial.

2

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE. Miller TP, et al. Among authors: salmon se. J Clin Oncol. 1991 Jan;9(1):17-24. doi: 10.1200/JCO.1991.9.1.17. J Clin Oncol. 1991. PMID: 1670642

3

Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model.

Lehnert M, Dalton WS, Roe D, Emerson S, Salmon SE. Lehnert M, et al. Among authors: salmon se. Blood. 1991 Jan 15;77(2):348-54. Blood. 1991. PMID: 1670760 Free article.

4

Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration.

Pennock GD, Dalton WS, Roeske WR, Appleton CP, Mosley K, Plezia P, Miller TP, Salmon SE. Pennock GD, et al. Among authors: salmon se. J Natl Cancer Inst. 1991 Jan 16;83(2):105-10. doi: 10.1093/jnci/83.2.105. J Natl Cancer Inst. 1991. PMID: 1988684

5

Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms.

Taylor CW, Grogan TM, Salmon SE. Taylor CW, et al. Among authors: salmon se. Blood. 1990 Mar 1;75(5):1114-8. Blood. 1990. PMID: 2306518 Free article.

6

Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation.

Dalton WS, Grogan TM, Rybski JA, Scheper RJ, Richter L, Kailey J, Broxterman HJ, Pinedo HM, Salmon SE. Dalton WS, et al. Among authors: salmon se. Blood. 1989 Feb 15;73(3):747-52. Blood. 1989. PMID: 2563664 Free article.

7

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BG, Taylor CW, Miller TP, Salmon SE. Dalton WS, et al. Among authors: salmon se. J Clin Oncol. 1989 Apr;7(4):415-24. doi: 10.1200/JCO.1989.7.4.415. J Clin Oncol. 1989. PMID: 2564428

8

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining.

Salmon SE, Grogan TM, Miller T, Scheper R, Dalton WS. Salmon SE, et al. J Natl Cancer Inst. 1989 May 3;81(9):696-701. doi: 10.1093/jnci/81.9.696. J Natl Cancer Inst. 1989. PMID: 2565403

9

Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines.

Salmon SE, Soehnlen B, Dalton WS, Meltzer P, Scuderi P. Salmon SE, et al. Blood. 1989 Oct;74(5):1723-7. Blood. 1989. PMID: 2790197 Free article.

10

In vitro evaluation of chemosensitizers for clinical reversal of P-glycoprotein-associated Taxol resistance.

Lehnert M, Emerson S, Dalton WS, de Giuli R, Salmon SE. Lehnert M, et al. Among authors: salmon se. J Natl Cancer Inst Monogr. 1993;(15):63-7. J Natl Cancer Inst Monogr. 1993. PMID: 7912531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters